Bupranolol: Difference between revisions
CSV import |
CSV import |
||
| Line 20: | Line 20: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 08:50, 10 February 2025
Bupranolol is a beta blocker that is used in the treatment of hypertension and angina pectoris. It is a non-selective beta blocker, meaning it blocks both beta-1 and beta-2 receptors. Bupranolol is also a partial agonist, which means it not only blocks the action of norepinephrine and epinephrine at the beta receptors, but also has some agonist activity of its own.
Pharmacology
Bupranolol is a non-selective beta blocker and partial agonist. It blocks the action of norepinephrine and epinephrine at the beta-1 and beta-2 receptors, which are found in the heart and blood vessels. This action reduces the heart rate, blood pressure, and strain on the heart. The partial agonist activity of bupranolol means it also has some activity of its own at the beta receptors, which can help to reduce the symptoms of withdrawal that can occur when stopping beta blockers.
Medical uses
Bupranolol is used in the treatment of hypertension and angina pectoris. By reducing the heart rate and blood pressure, it can help to prevent heart attacks and strokes in people with these conditions. It can also help to reduce the symptoms of angina, such as chest pain.
Side effects
Like all beta blockers, bupranolol can cause a range of side effects. These can include fatigue, cold hands and feet, slow heartbeat, and digestive problems. In some cases, it can also cause more serious side effects, such as heart failure or a slow heart rate that is too low.


